These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9137974)

  • 1. Pathogenesis and management of bone lesions in multiple myeloma.
    Bataille R; Manolagas SC; Berenson JR
    Hematol Oncol Clin North Am; 1997 Apr; 11(2):349-61. PubMed ID: 9137974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modeling of interactions between multiple myeloma and the bone microenvironment.
    Wang Y; Pivonka P; Buenzli PR; Smith DW; Dunstan CR
    PLoS One; 2011; 6(11):e27494. PubMed ID: 22110661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of multiple myeloma with navicular bone involvement.
    Yildizhan E; Kaynar L; Tiren N; Canoz O; Eser B
    Scott Med J; 2017 Nov; 62(4):152-155. PubMed ID: 28959919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Study of nine cases.
    Rossi JF; Bataille R; Chappard D; Alexandre C; Janbon C
    Am J Med; 1987 Jul; 83(1):10-6. PubMed ID: 3496790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo.
    Chantry AD; Heath D; Mulivor AW; Pearsall S; Baud'huin M; Coulton L; Evans H; Abdul N; Werner ED; Bouxsein ML; Key ML; Seehra J; Arnett TR; Vanderkerken K; Croucher P
    J Bone Miner Res; 2010 Dec; 25(12):2633-46. PubMed ID: 20533325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone involvement in multiple myeloma.
    Weinstein RS
    Am J Med; 1992 Dec; 93(6):591-4. PubMed ID: 1466353
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosis.
    Cavo M; Galieni P; Gobbi M; Baldrati L; Leardini L; Baccarani M; Tura S
    Acta Haematol; 1985; 74(1):27-30. PubMed ID: 3934904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological malignancies and the bone (myeloma excluded).
    Roux S; Mariette X
    Joint Bone Spine; 2000; 67(4):264-71. PubMed ID: 10963072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):285-95. PubMed ID: 1582975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma.
    Smith D; Yong K
    BMJ; 2013 Jun; 346():f3863. PubMed ID: 23803862
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
    Terpos E; Dimopoulos MA; Moulopoulos LA
    Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.
    Liu H; Liu Z; Du J; He J; Lin P; Amini B; Starbuck MW; Novane N; Shah JJ; Davis RE; Hou J; Gagel RF; Yang J
    Sci Transl Med; 2016 Aug; 8(353):353ra113. PubMed ID: 27559096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell neoplasms. Review of disease progression and report of a new variant.
    Nolan KD; Mone MC; Nelson EW
    Surg Oncol; 2005 Aug; 14(2):85-90. PubMed ID: 15993050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloma and bone disease: "the dangerous tango".
    Epstein J; Walker R
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):300-6. PubMed ID: 16728940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone hyperresorption in neoplastic diseases. Foreword].
    Vinceneux P
    Presse Med; 2000 Mar; 29(9):485-6. PubMed ID: 10745941
    [No Abstract]   [Full Text] [Related]  

  • 18. A Novel Strategy for Repairing Multiple Myeloma Bone Lesions: Lessons From Murine Models.
    Calvi LM; Hofbauer LC
    J Bone Miner Res; 2019 May; 34(5):781-782. PubMed ID: 31071234
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
    Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
    J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.